BioIndustry Association announce us as charity partner to help ‘turbo-charge’ bowel cancer research
Wednesday 7 December 2022
We’re delighted to announce the BioIndustry Association (BIA) has chosen Bowel Cancer UK as its charity partner for 2023.
The partnership with the BIA and its members across the UK’s life science’s ecosystem will play a pivotal role in raising awareness of bowel cancer, which could have a significant and lasting impact on research and understanding of the disease.
The BIA, the UK’s trade association for innovative life sciences and biotech industry, will support the charity through strategic opportunities and employee fundraising activities over the next 12 months. The partnership will be formally launched at the BIA’s Gala Dinner on Thursday 26 January 2023.
The partnership aligns closely with the BIA’s commitment to position the UK as a global hub for innovative research, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.
The two organisations are excited to work together to provide better outcomes for people affected with bowel cancer and to drive research that improves the prevention, early detection and treatment of the disease.
Steve Bates OBE, Chief Executive of the BIA, said: “Shortly before she died tragically young of bowel cancer last year, Aisling Burnand CBE wrote to me urging that ‘two organisations she cared deeply for unite’ for this partnership. She made the case that the BIA’s support in 2023 would help ‘turbo-charge the restart of Bowel Cancer UK’s research programme’ post-Covid. Health charities are a key component of the UK’s life science innovation ecosystem; their research is driven by patient insight and provides deep scientific and clinical disease expertise that UK SMEs can learn from and partner with. This year we look forward to using the positive power of the network to improve awareness and make connections to help tackle the UK’s second biggest cancer killer.”
Genevieve Edwards, Chief Executive at Bowel Cancer UK, said: “Many of the major advances in saving lives from bowel cancer have come through partnerships with organisations like those who are members of the BioIndustry Association, and that is why we are so thrilled to be chosen as their charity partner for 2023. Bowel cancer is the UK’s second biggest cancer killer but investing in research is the key to understanding how we can save more lives from this treatable and curable disease.
“We look forward to working with BIA and their valued members to drive positive change for patients and help to deliver improvements in bowel cancer survival in our lifetime. Central to this collaboration is the fearless and passionate former BIA CEO and our trustee Aisling Burnand CBE who we lost earlier this year. We know she would have been very proud of this partnership and that it will continue her important legacy.”
- Read more about our research
- Find out about our corporate partners
